Formulation of human antibodies for treating TNF-alpha associated disorders | Patent Publication Number 20170151329
US 20170151329 A1Patent NumberUS 09750808 B2
Application Number15418460
Filled DateJan 27, 2017
Priority DateAug 16, 2002
Publication DateJun 1, 2017
Original AssigneeAbbvie Inc.
Current AssigneeAbbvie Inc.
Inventor/ApplicantsLisa Baust
Hans-Juergen Krause
Michael Dickes
Hans-Juergen Krause
Michael Dickes
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.